PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Clinical trial NCT00819780 · COMPLETED

Trial details

NCT number: NCT00819780
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colon Cancer Colorectal Cancer Rectal Cancer Metastatic Colorectal Cancer

Start date: 2009-04-24
Primary completion: 2012-05-30
Enrollment: 285

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.